Grant List
Represents Grant table in the DB
GET /v1/grants?page%5Bnumber%5D=6&sort=-funder
{ "links": { "first": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1&sort=-funder", "last": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=1442&sort=-funder", "next": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=7&sort=-funder", "prev": "https://cic-apps.datascience.columbia.edu/v1/grants?page%5Bnumber%5D=5&sort=-funder" }, "data": [ { "type": "Grant", "id": "10595", "attributes": { "award_id": "1R21AR082657-01", "title": "Risk of Care Escalation after Non-Pharmacologic Treatment: Leveraging Real World Physical Therapy Data", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Neurological Disorders and Stroke (NINDS)" ], "program_reference_codes": [], "program_officials": [ { "id": 23897, "first_name": "CHARLES H.", "last_name": "WASHABAUGH", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2022-09-23", "end_date": "2024-08-31", "award_amount": 442750, "principal_investigator": { "id": 26624, "first_name": "TREVOR", "last_name": "LENTZ", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 246, "ror": "https://ror.org/00py81415", "name": "Duke University", "address": "", "city": "", "state": "NC", "zip": "", "country": "United States", "approved": true }, "abstract": "ABTRACT Musculoskeletal pain is a highly prevalent, costly, and burdensome condition commonly managed with opioids. Opioids do not often adequately address pain and have high risk for misuse and addiction. As a result, clinical practice guidelines strongly recommend non-pharmacologic treatments for musculoskeletal pain. Physical therapists are one of the most common providers of non-pharmacologic pain care in the US. However up to 43% of people receiving non-pharmacologic treatments delivered by physical therapists continue to seek care for their pain condition beyond the physical therapy episode, signaling a sub-optimal response to non- pharmacologic treatment. Additional treatments received often are higher risk, more invasive, and not recommended by current practice guidelines (e.g., opioids, surgery). The overarching aim of this project is to use real-world data to better understand risk factors for poor response to non-pharmacologic care delivered by physical therapists. This knowledge will enhance individual treatment decision making (e.g.., when to consider coordinated multimodal care) and provide direction on how to re-design non-pharmacologic care models to better address risk for poor response. In Aim 1, we will identify baseline factors associated with an unfavorable change in pain-related disability (a common precursor to escalation of care) among patients undergoing treatment by a physical therapist. Using the ATI Outcomes Registry Dataset, one of the largest outcomes datasets specific to physical therapy, we will derive common trajectories of self-reported disability following initiation of care (Sub-Aim 1a) and develop multivariable models to identify risk factors for an unfavorable disability change trajectory (Sub-Aim 1b). Aim 2 will use a separate, large claims-based dataset comprised of industrial union workers to identify baseline factors associated with escalation of care (i.e., subsequent use of imaging, opioids, injection, and surgery) following initiation of treatment by a physical therapist for musculoskeletal pain (Sub-Aim 2a). Sub-Aim 2b will use a subset of the claims-based dataset that is also included in the ATI Outcomes Registry to determine the incremental change in probability of care escalation associated with each one-point improvement in disability score. This information could help clinicians set disability improvement targets for a meaningful reduction in risk for escalating care. In exploratory analyses, we will assess how the mass disruption of healthcare delivery related to COVID-19 impacts these questions. We will perform stratified analyses for each Aim to 1) determine whether disability trajectories and factors associated with those trajectories have changed following the onset of COVID-19, and 2) establish whether receiving physical therapy prior to or after onset of COVID-19 is associated with differences in risk for poor outcomes. Collectively, this work aims to improve the delivery of non-pharmacologic care in an effort to reduce risk for opioid use and better address the substantial personal and societal impact of musculoskeletal pain.", "keywords": [ "Accounting", "Acute Pain", "Address", "Area", "COVID-19", "COVID-19 impact", "Caring", "Clinical", "Clinical Practice Guideline", "Data", "Data Set", "Decision Making", "Development", "Goals", "Growth", "Guidelines", "Health", "Health Care Costs", "Healthcare", "Helping to End Addiction Long-term", "Human", "Image", "Individual", "Industrialization", "Intervention", "Knowledge", "Modeling", "Musculoskeletal Pain", "Operative Surgical Procedures", "Opioid", "Outcome", "Pain", "Patient Self-Report", "Patients", "Persons", "Physical therapy", "Practice Guidelines", "Prior Therapy", "Probability", "Provider", "Recommendation", "Registries", "Research", "Risk", "Risk Factors", "Services", "Signal Transduction", "United States", "Work", "addiction", "base", "care seeking", "chronic pain", "cost", "deprivation", "design", "disability", "health care delivery", "high risk", "improved", "indexing", "modifiable risk", "multimodality", "opioid injection", "opioid use", "pain-related disability", "physical therapist", "response", "secondary analysis", "sociodemographics", "treatment response" ], "approved": true } }, { "type": "Grant", "id": "10725", "attributes": { "award_id": "1IK2RX003790-01A2", "title": "Neuromodulation for Rehabilitation of Post-Stroke Fatigue: An rTMS Pilot Study", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [], "start_date": "2022-11-01", "end_date": "2027-10-31", "award_amount": null, "principal_investigator": { "id": 26774, "first_name": "John Harvey", "last_name": "Kindred", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 1782, "ror": "", "name": "RALPH H JOHNSON VA MEDICAL CENTER", "address": "", "city": "", "state": "SC", "zip": "", "country": "United States", "approved": true }, "abstract": "The long-term goal of this proposed career development award (CDA-2) is to accelerate my training and development so that I can establish an independent line of research unraveling the causes and consequences of fatigue and to develop effective evidence-based therapies for fatigue in Veterans with neurological conditions. Before my collegiate studies, I served nine years on active duty in the United States Marine Corps and received an Honorable Discharge upon the expiration of my service contract. I completed my Ph.D. in Human Bioenergetics at Colorado State University in 2017. Upon graduation, I began a post-doctoral position at the Medical University of South Carolina working with Dr. Mark G. Bowden, PT, Ph.D. Shortly after starting my post- doc position, I acquired a WOC appointment at the Ralph H. Johnson VA Medical Center and was awarded a VA Rehabilitation Research and Development Career Development Award – 1 that began in Oct 2019. Since the beginning of my research journey, I have published 22 peer-reviewed manuscripts, 12 as the first author. My most recent publications have centered on measuring the neurophysiological state of the nervous system and relating that state to post-stroke disability. These most recent manuscripts are based on data collected at the laboratories at Ralph H. Johnson before my arrival and the co-authors include several of the members of this proposal’s mentorship team. Upon completing my CDA-1 (end date Sep 30, 2021), I have focused my attention on the neurophysiological biomarkers of post-stroke fatigue. This CDA-2 proposal will provide me with the opportunity to learn new neurophysiological assessment methods and advance my knowledge and ability to apply neuromodulatory treatments. These skills will provide me the foundation to build an independent VA- backed research program focusing on reducing the impact of fatigue in Veterans with an array of neurological conditions. The assembled mentorship team is composed of experts in post-stroke rehabilitation, neuromodulation, neuroimaging, and clinical assessment. Up to 92% of people post-stroke experience fatigue. Fatigue negatively affects physical and mental performance leading to a lower quality of life. Fatigue is also present in many other neurological populations within the Veteran community, such as traumatic brain injury, multiple sclerosis, and the newly coined phenomenon of Long-COVID. Advances in the knowledge and understanding of post-stroke fatigue are likely to lead to advances in other clinical populations within the Veteran community. The first aim is to test the effects of a well-established neuromodulatory therapy, repetitive transcranial magnetic stimulation (rTMS), on reducing the severity of post-stroke fatigue. This aim is predicated on theoretical principles obtained from the study of other neuro-psychiatric/-cognitive disorders and therapeutic attempts to reduce fatigue in other neurological illnesses. Participating Veterans will receive high-frequency rTMS to the frontal lobe, either the left prefrontal dorsolateral cortex or bilaterally to the motor cortices. These locations have been implicated in fatigue in other neurological conditions. I expect to show rTMS can be used to reduce post-stroke fatigue severity. However, the effectiveness and location of treatment may partially be dependent on individual characteristics. The second aim of the study is based on the skills and knowledge developed in the CDA-1, I plan on identifying additional neurophysiological biomarkers of fatigue. In this project, I will assess glutamatergic activity/signaling of the upper and lower extremity sensorimotor network of Veterans with and without post-stroke fatigue. I expect to show that the fatigued group will show glutamatergic dysfunction, measured by greater asymmetries in intracortical facilitation and the facilitatory response to paired associative stimulation, compared to the non-fatigued group. Identification of glutamate and related metabolites as a pathophysiological contributor to post-stroke fatigue may help in the development of new therapeutic approaches for post-stroke fatigue and fatigue in other neurological conditions.", "keywords": [ "Affect", "American Heart Association", "Anxiety", "Appointment", "Attention", "Award", "Back", "Behavior", "Bilateral", "Bioenergetics", "Biological Markers", "Caregivers", "Characteristics", "Chronic Fatigue Syndrome", "Clinical", "Clinical assessments", "Cognition Disorders", "Coin", "Colorado", "Communities", "Contract Services", "Data", "Development", "Doctor of Philosophy", "Effectiveness", "Environment", "Evidence based treatment", "FDA approved", "Fatigue", "Foundations", "Frequencies", "Functional disorder", "Glutamates", "Goals", "Human", "Individual", "Intervention", "K-Series Research Career Programs", "Knowledge", "Laboratories", "Lead", "Learning", "Left", "Lesion", "Location", "Long COVID", "Lower Extremity", "Magnetic Resonance Spectroscopy", "Manuscripts", "Measures", "Medical", "Medical center", "Mental Depression", "Mental disorders", "Mentorship", "Methods", "Motor", "Motor Cortex", "Multiple Sclerosis", "Nature", "Nervous System Physiology", "Nervous system structure", "Neuraxis", "Neurocognitive", "Neurologic", "Peer Review", "Performance", "Persons", "Pharmacology", "Physical Function", "Physical activity", "Physiologic pulse", "Pilot Projects", "Play", "Population", "Positioning Attribute", "Post-Traumatic Stress Disorders", "Postdoctoral Fellow", "Prefrontal Cortex", "Prevalence", "Psyche structure", "Publications", "Publishing", "Quality of life", "Recording of previous events", "Rehabilitation therapy", "Research", "Research Personnel", "Role", "Scientist", "Services", "Severities", "Signal Transduction", "South Carolina", "Stroke", "Structure", "System", "Testing", "Therapeutic", "Training", "Transcranial magnetic stimulation", "Traumatic Brain Injury", "United States", "Universities", "Update", "Upper Extremity", "Veterans", "Veterans Health Administration", "Work", "active duty", "base", "career", "career development", "chronic stroke", "cognitive function", "college", "cost", "disability", "effective intervention", "effective therapy", "efficacy testing", "evidence base", "experience", "expiration", "frontal lobe", "improved", "insight", "member", "military veteran", "multidisciplinary", "negative affect", "nervous system disorder", "neural circuit", "neuroimaging", "neurophysiology", "neuropsychiatry", "neuroregulation", "noninvasive brain stimulation", "novel", "novel therapeutic intervention", "post stroke", "programs", "psychologic", "rehabilitation re" ], "approved": true } }, { "type": "Grant", "id": "10571", "attributes": { "award_id": "1U01IP001182-01", "title": "RFA-IP-22-004, Multidisciplinary Approach to Understanding Vaccine Efficacy and Transmission of Viral Respiratory Tract Infections in the Real World", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [], "start_date": "2022-09-30", "end_date": "2027-09-29", "award_amount": 2483947, "principal_investigator": { "id": 26592, "first_name": "Stacey", "last_name": "House", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 827, "ror": "", "name": "WASHINGTON UNIVERSITY", "address": "", "city": "", "state": "MO", "zip": "", "country": "United States", "approved": true }, "abstract": "– COMPONENT A Influenza and SARS-CoV-2 are major causes of morbidity and mortality and constitute the leading causes of vaccine preventable deaths in the United States. A better understanding of vaccine effectiveness for these viral pathogens is critical to drive public health decisions and interventions. We propose utilizing a multidisciplinary approach to conduct a test-negative study to determine influenza and SARS-CoV-2 vaccine effectiveness in ambulatory patients with respiratory tract infections. The team of investigators includes experts in emergency medicine, infectious disease, pediatrics, epidemiology, information technology, molecular microbiology, virology, and genetics. This team has extensive experience in automated electronic medical record alerts, high-volume subject recruitment of ambulatory patients with respiratory tract infections, rapid escalation/de-escalation of recruitment efforts to match viral circulation patterns, respiratory and blood sample processing and shipment, quality data collection and verification, and viral genomic sequencing necessary to ensure the success of this project. The proposed study will encompass the following specific aims: 1)Utilize innovative automated alerting strategies to identify and recruit a diverse population of ambulatory patients with acute respiratory illnesses; 2) Estimate influenza and SARS-CoV-2 vaccine effectiveness using a test- negative study design in the general population as well as different demographic subgroups.; 3) Explore factors that influence influenza and SARS-CoV-2 vaccine effectiveness such as co-morbidities, vaccination type and schedule, and social determinants of health; 4) Determine effect of viral vaccination status on health outcomes in ambulatory patients with influenza and SARS-CoV-2 infection; 5) Contribute biospecimens and viral genomic sequencing data to a national repository of subjects with PCR-confirmed influenza or SARS-CoV-2 infection. To accomplish these goals, we will enroll at least 1000 ambulatory patients/year with acute respiratory tract infections in the proposed study. The subject population will be identified from the emergency departments of 3 large hospitals in the St. Louis area and their associated outpatient clinics. The available patient population at these enrolling sites is diverse with respect to race, ethnicity, age, socioeconomic status, and medical care access which will enhance the generalizability of the study outcomes to the US population.", "keywords": [], "approved": true } }, { "type": "Grant", "id": "10967", "attributes": { "award_id": "5F31CA261086-02", "title": "Impact of the intestinal microbiota on CAR T cell therapy response", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Cancer Institute (NCI)" ], "program_reference_codes": [], "program_officials": [ { "id": 24807, "first_name": "ANTHONY THOMAS", "last_name": "Dibello", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2021-12-01", "end_date": "2024-11-30", "award_amount": 46752, "principal_investigator": { "id": 24808, "first_name": "Pamela", "last_name": "Herrera", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 825, "ror": "", "name": "WEILL MEDICAL COLL OF CORNELL UNIV", "address": "", "city": "", "state": "NY", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [], "awardee_organization": { "id": 825, "ror": "", "name": "WEILL MEDICAL COLL OF CORNELL UNIV", "address": "", "city": "", "state": "NY", "zip": "", "country": "United States", "approved": true }, "abstract": "Abstract: According to the National Cancer Institute, every 9 minutes a person in the USA dies from a blood cancer1. While initial responses are achievable with conventional chemotherapy, relapsed/refractory disease remains a significant problem. Chimeric antigen receptor (CAR) T cell-based immunotherapy is a revolutionarily new approach against these stubborn cancers. Although several clinical trials have shown remarkable efficacy, there remains a subset of patients who do not respond to CAR T therapy and/or experience toxicity as a result of immune activation in the form of cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome (ICANS)2-6. As preserving of this a result, managing these iatrogenic toxicities while still high on-target efficacy has become a fundamental part of the ongoing development immunotherapy. To date, several studies have demonstrated the strong interplay between commensal microbiota and its effect on both the innate and adaptive immune system, such as the regulation of T cell function7-18. Studies suggest that the intestinal microbiota may be a crucial host factor that modulates the response to immunotherapy7,8,19-21. Lymphodepleting conditioning and administration of antibiotics regularly disrupt the natural intestinal flora leading to dysbiosis and expansion of unfavorable antibiotic-resistance pathogenic taxa22. Although the microbiome has been associated with clinical response in allogeneic-hematopoietic stem cell transplants, checkpoint blockade, and adoptive T cell therapy10,20,23-26, it is still unknown as to how microbiome manipulations affect CAR T cell therapy response. Preliminary data from our center shows that exposure to antibiotics prior to CAR T cell infusion decreases overall survival and progression free survival of patients. Additionally, we have found that specific bacterial taxa in the baseline stool of patients prior to CAR T cell infusion, are associated with complete response. These enhanced preliminary studies support outcome of CAR T cell therapy. a causal role for the intestinal microbiota in The central hypothesis for this project is that strategic microbiota modulation can enhance CAR T cell therapy response by preserving favorable taxa for improved effector function of CAR T cells via a pro-inflammatory milieu. This hypothesis will be tested by pursuing two project aims: 1) Investigating the role of the intestinal microbiota on CAR T Cell therapy response; and 2) Evaluating the impact of broad-spectrum antibiotics on CAR T cell effector function.", "keywords": [ "Adaptive Immune System", "Affect", "Allogenic", "Antibiotic Resistance", "Antibiotics", "Bacteria", "Biological Markers", "CAR T cell therapy", "Cell physiology", "Cellular immunotherapy", "Clinic", "Clinical", "Clinical Trials", "Cyclophosphamide", "Cytotoxic T-Lymphocytes", "Data", "Development", "Effector Cell", "Enzymes", "Epithelial Cells", "Exposure to", "Feces", "Hematopoietic Neoplasms", "Hematopoietic Stem Cell Transplantation", "IL18 gene", "Iatrogenesis", "Immune", "Immunotherapy", "In complete remission", "Inflammatory", "Inflammatory Response", "Infusion procedures", "Innate Immune System", "Integration Host Factors", "Interleukin-12", "Interleukin-18", "Intestinal Secretions", "Intestines", "Knowledge", "Laboratories", "Malignant Neoplasms", "Mediating", "Modeling", "Mus", "National Cancer Institute", "Nature", "Neurotoxicity Syndromes", "Outcome", "Pathogenicity", "Patients", "Persons", "Phenotype", "Play", "Progression-Free Survivals", "Property", "Publications", "Refractory Disease", "Regulatory T-Lymphocyte", "Relapse", "Research", "Research Personnel", "Research Project Grants", "Role", "T cell regulation", "T cell therapy", "Testing", "Toxic effect", "Tumor-Infiltrating Lymphocytes", "antitumor effect", "cancer immunotherapy", "chemotherapy", "chimeric antigen receptor", "chimeric antigen receptor T cells", "commensal microbes", "conditioning", "cytokine", "cytokine release syndrome", "dysbiosis", "effector T cell", "experience", "gut microbiome", "gut microbiota", "immune activation", "immune checkpoint blockade", "immunoregulation", "improved", "inflammatory milieu", "microbial", "microbiome", "microbiota", "neurotoxicity", "novel strategies", "patient oriented", "patient response", "patient subsets", "personalized approach", "preservation", "profiles in patients", "refractory cancer", "responders and non-responders", "response", "success", "treatment response", "tumor", "tumor microenvironment" ], "approved": true } }, { "type": "Grant", "id": "10951", "attributes": { "award_id": "5R21EB032644-02", "title": "Background Oriented Schlieren (BOS) Visualization for Evaluation of Risk in Aerosol-Generating Procedures", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Biomedical Imaging and Bioengineering (NIBIB)" ], "program_reference_codes": [], "program_officials": [ { "id": 23661, "first_name": "AFROUZ AZARI", "last_name": "Anderson", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2022-01-01", "end_date": "2024-11-30", "award_amount": 208902, "principal_investigator": { "id": 23662, "first_name": "Nelson Scott", "last_name": "Howard", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 497, "ror": "https://ror.org/051fd9666", "name": "Case Western Reserve University", "address": "", "city": "", "state": "OH", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [ { "id": 23663, "first_name": "Bryan", "last_name": "Schmidt", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 497, "ror": "https://ror.org/051fd9666", "name": "Case Western Reserve University", "address": "", "city": "", "state": "OH", "zip": "", "country": "United States", "approved": true }, "abstract": "Aerosol-generating procedures (AGPs) are medical procedures that produce aerosols that can be laden with pathogens if the patient has a viral infection, such as SARS-CoV-2 or influenza. These aerosols pose a significant risk to health care workers, as they can linger in the air for extended periods of time and are small enough to bypass ordinary surgical masks. There is currently no established, unambiguous way to evaluate the risks to healthcare workers associated with a specific AGP, nor is there a rigorous method by which to assess a proposed risk-mitigation strategy. To address this gap, a flow visualization technique must be developed that can be applied in a clinical setting during actual medical procedures and is capable of detecting aerosol-laden flows produced by AGPs or potential AGPs. In this R21 proposal, we will adapt background-oriented schlieren (BOS) visualization, a method from fluid mechanics, into a technique that can be applied to study flows produced by AGPs. The R21 project is high risk with no published preliminary data, but the PIs have successfully demonstrated visualziation of aerosols produced by jet ventilation, a specific type of AGP, using BOS in a proof-of-concept experiment. The proposed work is significant and timely, as assessment of the risk associated with AGPs is extremely important in the context of the COVID-19 pandemic. We will use the novel BOS technique to assess risks and evaluate mitigation strategies for three specific AGPs in both ex vivo and in vivo conditions. Specific Aim 1: Develop a human-scale BOS system and establish a procedure for evaluating the risk of AGPs in a clinical setting. Specific Aim 2: Quantify the risk of aerosol exposure under different simulated and in-vivo conditions, and identify strategies to mitigate the risks. The significance and impact of the proposed research will be in developing a tool for unambiguously evaluat- ing the risks associated with AGPs in realistic clinical settings, and urgently-needed risk assessments for three specific AGPs and experimentally verified risk mitigation strategies for each.", "keywords": [ "2019-nCoV", "Address", "Aerosols", "Air", "Algorithms", "Bypass", "COVID-19 pandemic", "Clinical", "Communicable Diseases", "Data", "Dimensions", "Disease Outbreaks", "Evaluation", "Future", "Goals", "Health Personnel", "Health protection", "Human", "Image", "Influenza", "Intubation", "Knowledge", "Light", "Lighting", "Liquid substance", "Manikins", "Mechanics", "Medical", "Methods", "Optics", "Oral cavity", "Patients", "Pattern", "Procedures", "Publishing", "Research", "Risk", "Risk Assessment", "System", "Techniques", "Time", "Tracheostomy procedure", "Virus Diseases", "Visualization", "Work", "base", "density", "design", "experimental study", "high risk", "image processing", "in vivo", "indexing", "novel", "pandemic disease", "pathogen", "portability", "prototype", "risk minimization", "risk mitigation", "surgical mask", "tool", "transmission process", "ventilation" ], "approved": true } }, { "type": "Grant", "id": "10783", "attributes": { "award_id": "1R34MH129542-01A1", "title": "Adaptation of Critical Time Intervention for Young Adults with Mental Health Challenges in the Transition from Homelessness to Housing", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Mental Health (NIMH)" ], "program_reference_codes": [], "program_officials": [ { "id": 11582, "first_name": "Susan", "last_name": "Azrin", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2022-12-10", "end_date": "2025-11-30", "award_amount": 286176, "principal_investigator": { "id": 26858, "first_name": "Sarah Carter", "last_name": "Narendorf", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 231, "ror": "https://ror.org/048sx0r50", "name": "University of Houston", "address": "", "city": "", "state": "TX", "zip": "", "country": "United States", "approved": true }, "abstract": "Young adults experiencing homelessness (YAEH) have high prevalence of mental disorders, however, they face unique access barriers to mental health services combined with low recognition of mental health symptoms, leading to low rates of mental health service utilization. The point of transition from homelessness to housing presents a period of opportunity to identify mental health symptoms and connect and engage YAEH into mental health services to reduce symptoms and promote housing stability. The COVID-19 pandemic has heightened mental health symptoms and increased the need for services among YAEH, but it has also resulted in recovery funds to increase housing supports in many communities. There is a critical need to develop interventions that can support YAEH with mental health challenges as they make the transition from homelessness to housing as more supported housing becomes available. Critical Time Intervention (CTI), a structured, time limited case management intervention has demonstrated success with adults with serious mental illness in multiple randomized controlled trials but it has not been tested in YAEH. The goal of this study is to adapt CTI for the context of transition from homelessness to supported housing within the rapid rehousing program, integrating mental health specific content from a young adult treatment model, C4, to develop CTI-YAMH (young adult mental health), and then test the new intervention in a feasibility pilot. Specifically, we aim to: Aim 1: Refine the draft CTI- YAMH intervention (treatment, training and assessment protocols) to ensure the target mechanisms are adequately addressed for stabilizing housing and mental health, utilizing an iterative stakeholder feedback process to finalize the manuals for pilot testing, then Aim 2: Conduct an open trial of the adapted CTI- YAMH intervention to assess the feasibility of randomization procedures, refine outcome measures, assess acceptability, and examine the preliminary signal of impact of the intervention. This innovative study targets a critical point of intervention, the transition from homelessness to housing, for an extremely marginalized group (YAEH), utilizing an innovative adaptation framework, ADAPT-ITT, to systematically adapt CTI in partnership with youth with lived expertise and community providers. The CTI-YAMH intervention aims to support a population with high unmet need for mental health services through a model that can be paired with rapid rehousing, a supportive housing model widely used in communities across the U.S. Results from this R34 study lay the foundation for a fully powered RCT of the CTI-YAMH intervention in a future R01 study.", "keywords": [ "Address", "Administrator", "Adult", "Age", "Anxiety", "COVID-19 pandemic", "Caring", "Case Management", "Case Manager", "Characteristics", "Clinic", "Communities", "Continuity of Patient Care", "Coupled", "Development", "Diagnosis", "Effectiveness", "Elements", "Ensure", "Evidence based intervention", "Evidence based practice", "Face", "Feedback", "Focus Groups", "Foundations", "Funding", "Future", "Goals", "Health", "High Prevalence", "Homelessness", "Housing", "Individual", "Institute of Medicine (U.S.)", "Intervention", "Intervention Studies", "Investigational Therapies", "Manuals", "Mental Health", "Mental Health Services", "Mental disorders", "Mentors", "Modeling", "Moods", "National Institute of Mental Health", "Outcome Measure", "Outcomes Research", "Outpatients", "Phase", "Population", "Population Heterogeneity", "Procedures", "Process", "Protocols documentation", "Provider", "Randomized", "Randomized Controlled Trials", "Recovery", "Recurrence", "Research Priority", "Self Efficacy", "Services", "Signal Transduction", "Social support", "Structure", "Symptoms", "Testing", "Time", "Training", "Trauma", "United States", "Variant", "Work", "Youth", "base", "care coordination", "experience", "family support", "federal policy", "health service use", "housing instability", "improved", "innovation", "marginalized population", "member", "peer support", "person centered", "pilot test", "pilot trial", "preference", "primary outcome", "programs", "reduce symptoms", "service utilization", "severe mental illness", "skill acquisition", "social stigma", "substance use", "success", "supported housing", "therapy design", "therapy development", "working group", "young adult" ], "approved": true } }, { "type": "Grant", "id": "10699", "attributes": { "award_id": "1U01MD018313-01", "title": "Increasing representation of Black communities in COVID-19 home testing and surveillance data", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "NIH Office of the Director" ], "program_reference_codes": [], "program_officials": [ { "id": 6121, "first_name": "Priscah", "last_name": "Mujuru", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2022-11-01", "end_date": "2024-10-31", "award_amount": 570231, "principal_investigator": { "id": 22449, "first_name": "Heather", "last_name": "Bradley", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [ { "id": 964, "ror": "https://ror.org/03qt6ba18", "name": "Georgia State University", "address": "", "city": "", "state": "GA", "zip": "", "country": "United States", "approved": true } ] }, "other_investigators": [ { "id": 26755, "first_name": "Natasha F", "last_name": "De Veauuse Brown", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 265, "ror": "https://ror.org/03czfpz43", "name": "Emory University", "address": "", "city": "", "state": "GA", "zip": "", "country": "United States", "approved": true }, "abstract": null, "keywords": [], "approved": true } }, { "type": "Grant", "id": "10619", "attributes": { "award_id": "1R21MD016947-01A1", "title": "Multivariate spatiotemporal models to quantify disparities in COVID-19 health outcomes", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute on Minority Health and Health Disparities (NIMHD)" ], "program_reference_codes": [], "program_officials": [ { "id": 8046, "first_name": "Nathaniel", "last_name": "Stinson", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2022-09-19", "end_date": "2024-05-31", "award_amount": 242655, "principal_investigator": { "id": 26661, "first_name": "Brian", "last_name": "Neelon", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 1179, "ror": "https://ror.org/012jban78", "name": "Medical University of South Carolina", "address": "", "city": "", "state": "SC", "zip": "", "country": "United States", "approved": true }, "abstract": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has created a global public health crisis since its onset in late 2019. Although the pandemic has affected all communities, recent work suggests that socially vulnerable populations have been disproportionately impacted by the disease. Mounting evidence has found that the pandemic disproportionately affects people of color, older individuals, and those of lower socioeconomic status. To date, however, there has been no comprehensive spatiotemporal analysis of the relationship between social vulnerability and COVID-19 outcomes at a national scale and over an extended period of time, in part because the statistical tools needed for such an analysis are lacking. The objective of the proposal is to develop multivariate models to identify spatiotemporal trends in correlated count outcomes, and to use these models to quantify disparities in COVID-19 infection, death, testing, hospitalizations, and vaccinations across socially vulnerable communities. Aim 1 proposes a Bayesian multivariate spatiotemporal model to quantify disparities in COVID-19 infection, death, testing, hospitalization, and vaccination rates over time across US counties. Social vulnerability exposures are incorporated into the model in a nonlinear and interactive manner through a novel multivariate kernel machine regression. Aim 2 extends the method to the zero inflated setting by developing a Bayesian multivariate zero- inflated negative binomial model to quantify disparities in COVID-19 trends over time and across counties. Aim 3 develops computationally scalable Bayesian software for implementation of the methods. The pandemic has caused enduring disruptions to the health care system that will disproportionately impact vulnerable populations for years to come. The statistical methods developed here will play a critical role in promoting health equity and mitigating long-standing disparities exacerbated by the pandemic.", "keywords": [ "2019-nCoV", "Accounting", "Address", "Affect", "Area", "Binomial Model", "COVID-19", "COVID-19 disparity", "COVID-19 pandemic", "Cessation of life", "Code", "Color", "Communities", "Computer software", "County", "Data", "Dependence", "Development", "Disease", "Disease Outbreaks", "Economically Deprived Population", "Equilibrium", "Exhibits", "Exposure to", "Geographic Locations", "Goals", "Health", "Health Disparities Research", "Health system", "Healthcare", "Healthcare Systems", "Hospitalization", "Incidence", "Individual", "Infection", "Institutes", "Joints", "Methods", "Modeling", "Outcome", "Play", "Public Health", "Research", "Resources", "Role", "SARS-CoV-2 infection", "Sampling", "Statistical Methods", "Testing", "Time", "Time trend", "Update", "Vaccination", "Vaccines", "Vulnerable Populations", "Work", "flexibility", "health equity promotion", "health inequalities", "high dimensionality", "infection rate", "long-standing disparities", "low socioeconomic status", "minority health", "minority health disparity", "novel", "pandemic disease", "people of color", "response", "social", "social vulnerability", "spatiotemporal", "tool", "trend", "user-friendly", "vulnerable community" ], "approved": true } }, { "type": "Grant", "id": "10539", "attributes": { "award_id": "1U01EB033305-01", "title": "A point-of-care device using Single Molecule Array (Simoa) to measure viral antigens in nasal swabs, saliva, and blood", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [ "National Institute of Biomedical Imaging and Bioengineering (NIBIB)" ], "program_reference_codes": [], "program_officials": [ { "id": 6433, "first_name": "Tiffani Bailey", "last_name": "Lash", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "start_date": "2022-09-22", "end_date": "2025-08-31", "award_amount": 1705157, "principal_investigator": { "id": 26550, "first_name": "David C", "last_name": "Duffy", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [ { "id": 26551, "first_name": "Nira", "last_name": "Pollock", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] } ], "awardee_organization": { "id": 1940, "ror": "", "name": "QUANTERIX CORPORATION", "address": "", "city": "", "state": "MA", "zip": "", "country": "United States", "approved": true }, "abstract": "The goal of this project is to develop a simple-to-use, low-cost, and small instrument and associated consumable for point-of-care (POC) diagnoses based on the ultrasensitive detection of proteins. The proposed system will combine detection of proteins using the Single Molecule Array (Simoa; Quanterix Corporation) technology and assay processing using digital microfluidics (DMF) to enable POC immunoassays with the sensitivity and specificity of nucleic acid amplification tests without the need for nucleic acid purification or amplification, and with the simplicity, sample type flexibility, and diagnostic performance to deliver central lab diagnostic quality in POC settings. The proposed system would be composed of a sample- to-answer, random access, benchtop instrument utilizing a universal consumable design accepting a broad range of minimally processed samples relevant to POC diagnosis of disease, including swab, saliva, and blood (including fingerstick) samples. We will first apply this technology to the diagnosis of COVID-19 and influenza, optimizing existing assays for SARS-CoV-2 N-protein and developing new multiplexed assays for influenza A and B antigens, along with simple sample preparation methods, for testing of nasal/nasopharyngeal (NP) swab (SARS-CoV-2/influenza) and saliva/blood (SARS-CoV-2 only) samples. This project—a collaboration between Quanterix (Dr. Duffy, co-PI), Boston Children's Hospital (Dr. Pollock, co-PI), and University of Toronto (Dr. Wheeler, co-investigator)—has four specific aims to achieve these goals. First, we will develop the key technologies to enable the POC system, namely: a low-cost Simoa imager with a small form factor; single molecule labels that do not require sealing in microwell arrays; and, the DMF building blocks for assay processing, resulting in an integrated Simoa-DMF device. Second, we will design, develop, and test Simoa POC instruments and consumables, first in prototype and then for test validation. Third, we will optimize/develop and validate analytically Simoa assays (including sample preparation options) for SARS- CoV-2 (nasal swab, saliva, blood) and multiplex influenza A/B (NP swab) antigens, and test them on the prototype Simoa POC system. Finally, we will clinically validate the POC antigen tests against gold-standard molecular tests for all sample types using discarded/banked clinical samples, and evaluate performance of the POC system in POC settings using contrived clinical samples. User feedback will inform development throughout the proposal. The long-term objective of this research is to develop a broadly enabling technology that would allow the diagnosis of diseases using ultrasensitive protein detection at the POC in a small, low-cost benchtop system. This type of capability is available for molecular testing but not for protein detection, and would combine high sensitivity with low cost and an alternative supply chain to support diagnosis of infectious diseases in diverse clinical settings. This system would be a critical new diagnostic tool ready both for routine POC diagnosis of infectious diseases and to benefit the world in the event of the next pandemic.", "keywords": [ "2019-nCoV", "Adult", "Anterior", "Antigens", "Biological Assay", "Blood", "Blood specimen", "Boston", "COVID-19", "COVID-19 assay", "COVID-19 diagnosis", "COVID-19 pandemic", "COVID-19 testing", "Child", "Childhood", "Clinical", "Collaborations", "Communicable Diseases", "Detection", "Development", "Devices", "Diagnosis", "Diagnostic", "Early Diagnosis", "Environment", "Enzyme-Linked Immunosorbent Assay", "Event", "FDA Emergency Use Authorization", "Feedback", "Goals", "Gold", "Immunoassay", "Infection", "Infection Control", "Influenza", "Influenza A virus", "Influenza B Virus", "Intervention", "Kenya", "Label", "Measurement", "Measures", "Methods", "Microfluidic Microchips", "Microfluidics", "Molecular", "Nose", "Nucleic Acid Amplification Tests", "Nucleic Acids", "Nucleoproteins", "Outcome", "Patients", "Pediatric Hospitals", "Performance", "Point of Care Technology", "Point-of-Care Systems", "Preparation", "Price", "Process", "Proteins", "Refugee Camp", "Research", "Research Personnel", "Running", "SARS-CoV-2 B.1.617.2", "SARS-CoV-2 antigen", "Saliva", "Sampling", "Sensitivity and Specificity", "Swab", "System", "Systems Development", "Technology", "Testing", "Time", "Universities", "Validation", "Viral", "Viral Antigens", "Virus", "Virus Diseases", "antigen detection", "antigen test", "assay development", "base", "communicable disease diagnosis", "cost", "design", "diagnostic tool", "digital", "disease diagnosis", "electric field", "flexibility", "imager", "improved", "innovation", "instrument", "microfluidic technology", "miniaturized device", "multiplex assay", "nasal swab", "nasopharyngeal swab", "novel diagnostics", "nucleic acid purification", "pandemic disease", "pathogen", "point of care", "point of care testing", "point-of-care diagnosis", "point-of-care diagnostics", "price lists", "prototype", "saliva sample", "seal", "single molecule", "targeted treatment", "usability", "user-friendly", "validation studies" ], "approved": true } }, { "type": "Grant", "id": "10791", "attributes": { "award_id": "1I01HX002941-01A2", "title": "A web-based program to improve chronic illness self-management by engaging patients and informal caregivers", "funder": { "id": 4, "ror": "https://ror.org/01cwqze88", "name": "National Institutes of Health", "approved": true }, "funder_divisions": [], "program_reference_codes": [], "program_officials": [], "start_date": "2022-10-01", "end_date": "2026-09-30", "award_amount": null, "principal_investigator": { "id": 26867, "first_name": "Ranak", "last_name": "Trivedi", "orcid": null, "emails": "", "private_emails": "", "keywords": null, "approved": true, "websites": null, "desired_collaboration": null, "comments": null, "affiliations": [] }, "other_investigators": [], "awardee_organization": { "id": 1497, "ror": "", "name": "VETERANS ADMIN PALO ALTO HEALTH CARE SYS", "address": "", "city": "", "state": "CA", "zip": "", "country": "United States", "approved": true }, "abstract": "Background: For the 80% of older Americans who have at least one chronic condition, sharing self- management responsibilities with caregivers (relatives or friends) predicts longevity, better health, better quality of life, and fewer hospitalizations. Caregivers often support patients in their self-management efforts. This can bring patients and caregivers closer but can also generate stress for both that can interfere with self- management. Yet, self-management programs rarely support the coping needs of patient-caregiver dyads. Significance: There are more than 5 million caregivers of Veterans; 75% of older Veterans receive some caregiver support. Caregivers incur individual financial and emotional costs even as they provide unpaid care. Having an effective self-management strategy that addresses the needs of both can improve outcomes and quality of life for millions of Veterans who suffer from chronic illnesses and their caregivers. This project addresses the priorities “Long-term care and Caregiving,” “Virtual Care/Telehealth,” and “Access to Care” and is consistent with the legislative goals of the MISSION Act. Innovation and Impact: This highly innovative proposal uses the novel concept that strengthening the interpersonal relationships between Veterans and caregivers can improve the self-management of chronic conditions. It challenges current clinical paradigms by addressing the collective stress coping needs of dyads. It is methodologically innovative because unlike many behavioral intervention trials, it assesses barriers and facilitators to plan for future implementation. Our focus on technology-enabled tools is timely given how COVID19 has transformed care delivery. This project takes advantage of the unique capabilities of the VA health system to explore questions including robust caregiver support and virtual care programs. Specific Aims: With investments from VA HSR&D, we have developed and successfully pilot tested a new theoretically-derived technology called Web-based Self-care Using Collaborative Coping EnhancEment in Diseases (web-SUCCEED). We propose to conduct a randomized clinical trial comparing web-SUCCEED to an enhanced usual care (EUC) control. We will conduct a formative evaluation guided by the Consolidated Framework of Implementation Research (CFIR) to accelerate future implementation. 1. Assess whether web-SUCCEED improves Veteran outcomes of self-management compared to EUC, 4 weeks and 6 months following randomization. 2a. Assess whether web-SUCCEED improves patient stress and quality of life. 2b. Assess whether web-SUCCEED improves caregiver stress, quality of life and caregiver burden. 2c. Examine communication, dyadic coping, mutuality, and relationship quality as mediators of primary and secondary outcomes (Aims 1, 2a, 2b). 3. Guided by CFIR, conduct a formative evaluation involving key stakeholder interviews to understand barriers and facilitators of future implementation. Methodology: We will recruit 280 cognitively intact Veterans from VA Palo Alto Health Care System who are managing at least one common chronic condition, and their caregivers. Veteran-caregiver dyads will be randomized 1:1 to web-SUCCEED or EUC. Veteran and caregiver assessments will take place at baseline, then again at 4 weeks and 6 months. The formative evaluation will be guided by CFIR and involve semi- structured interviews with clinical staff, providers, and facility leaders in Year 4. Next Steps: Our formative evaluation will set us up for implementation studies to evaluate web-SUCCEED in a wider array of clinical settings and facilities. Existing operational partnerships will facilitate wider clinical implementation and moving research into practice. Our innovative project, strong investigative team and operational partnerships will ensure a successful study that has the potential to shift clinical paradigms.", "keywords": [ "Address", "Adult", "American", "Award", "Behavior Therapy", "Behavioral", "COVID-19", "Caregiver Burden", "Caregiver support", "Caregivers", "Caring", "Chronic", "Chronic Disease", "Chronically Ill", "Clinical", "Cognitive", "Collaborations", "Communication", "Consolidated Framework for Implementation Research", "Data", "Diabetes Mellitus", "Diagnosis", "Disease", "Distress", "Emotional", "Ensure", "Equipment and supply inventories", "Face", "Family Caregiver", "Family member", "Friends", "Funding", "Gender", "Goals", "Grant", "Health", "Health Services Accessibility", "Health system", "Healthcare Systems", "Hospitalization", "Individual", "Internet", "Interpersonal Relations", "Intervention Trial", "Interview", "Investments", "Learning", "Life Style", "Long-Term Care", "Longevity", "Maintenance", "Measures", "Mediator of activation protein", "Medication Management", "Mental Depression", "Methodology", "Myocardial Ischemia", "Online Systems", "Outcome", "Pain", "Patients", "Persons", "Pilot Projects", "Practice Management", "Primary Care Physician", "Prognosis", "Provider", "Psychologist", "Quality of life", "Randomized", "Randomized Clinical Trials", "Reporting", "Resources", "Scientist", "Self Care", "Self Management", "Services", "Stress", "Stress and Coping", "Structure", "Technology", "Telephone", "Testing", "Time", "Veterans", "Visual", "Work", "acceptability and feasibility", "arm", "behavior change", "care delivery", "caregiver stress", "caregiving", "clinical implementation", "clinical practice", "coping", "cost", "design", "effectiveness evaluation", "experience", "follow-up", "formative assessment", "future implementation", "implementation study", "improved", "improved outcome", "informal caregiver", "innovation", "member", "mobile application", "novel", "peer support", "pilot test", "positive emotional state", "primary outcome", "programs", "recruit", "research to practice", "retention rate", "rural area", "secondary outcome", "self-management program", "skills", "telehealthcare", "telephone-based", "tool", "treatment as usual", "trial comparing", "usability", "user centered design", "virtual healthcare", "web site" ], "approved": true } } ], "meta": { "pagination": { "page": 6, "pages": 1442, "count": 14420 } } }